Clinical determinants of calcineurin inhibitor disposition: a mechanistic review

T Vanhove, P Annaert, DRJ Kuypers - Drug metabolism reviews, 2016 - Taylor & Francis
The calcineurin inhibitors (CNIs) tacrolimus and cyclosporine are widely used
immunosuppressive drugs characterized by high pharmacokinetic and pharmacodynamic …

An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients

S Masuda, K Inui - Pharmacology & therapeutics, 2006 - Elsevier
Calcineurin inhibitors, tacrolimus (FK506) and cyclosporine (ciclosporin A), are the primary
immunosuppressive agents used on recipients of organ transplantations. The hepatic …

From gut to kidney: transporting and metabolizing calcineurin-inhibitors in solid organ transplantation

N Knops, E Levtchenko, B van den Heuvel… - International journal of …, 2013 - Elsevier
Since their introduction circa 35 years ago, calcineurin-inhibitors (CNI) have become the
cornerstone of immunosuppressive therapy in solid organ transplantation. However, CNI's …

Pharmacogenetics of calcineurin inhibitors in renal transplantation

E Coto, B Tavira - Transplantation, 2009 - journals.lww.com
Cyclosporine A and tacrolimus (Tac) are inmunosuppresive drugs with a narrow therapeutic
range. Underdosing is associated with organ rejection, whereas overdosing could result in …

Biomarkers for individualized dosage adjustments in immunosuppressive therapy using calcineurin inhibitors after organ transplantation

R Fu, S Tajima, K Suetsugu, H Watanabe… - Acta Pharmacologica …, 2019 - nature.com
Calcineurin inhibitors (CNIs), such as cyclosporine A and tacrolimus, are widely used
immunosuppressive agents for the prevention of post-transplantation rejection and have …

The pharmacogenetics of calcineurin inhibitor–related nephrotoxicity

DA Hesselink, R Bouamar… - Therapeutic drug …, 2010 - journals.lww.com
Chronic calcineurin inhibitor (CNI)-induced nephrotoxicity is associated with prolonged use
of cyclosporine and tacrolimus and has been observed after all types of transplantation, as …

The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?

DA Hesselink, T Van Gelder… - Pharmacogenomics, 2005 - Taylor & Francis
The immunosuppressive drugs cyclosporin (CsA) and tacrolimus (Tac) are widely used to
prevent acute rejection following solid-organ transplantation. However, the clinical use of …

Pharmacokinetics, pharmacodynamics and pharmacogenetics of tacrolimus in kidney transplantation

M Yu, M Liu, W Zhang, Y Ming - Current drug metabolism, 2018 - ingentaconnect.com
Background: Tacrolimus (Tac, or FK506), a calcineurin inhibitor (CNI), is the first-line
immunosuppressant which consists of the footstone as immunosuppressive regimens in …

The many faces of calcineurin inhibitor toxicity—What the FK?

SS Farouk, JL Rein - Advances in Chronic Kidney Disease, 2020 - Elsevier
Calcineurin inhibitors (CNIs) are both the savior and Achilles' heel of kidney transplantation.
Although CNIs have significantly reduced rates of acute rejection, their numerous toxicities …

Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I

CE Staatz, LK Goodman, SE Tett - Clinical pharmacokinetics, 2010 - Springer
The calcineurin inhibitors ciclosporin (cyclosporine) and tacrolimus are immunosuppressant
drugs used for the prevention of organ rejection following transplantation. Both agents are …